Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

enVVeno Medical (NVNO) Shares Outstanding (Weighted Average) (2017 - 2026)

enVVeno Medical has reported Shares Outstanding (Weighted Average) over the past 4 years, most recently at $1.3 million for Q4 2020.

  • For Q4 2020, Shares Outstanding (Weighted Average) rose 104.86% year-over-year to $1.3 million; the TTM value through Dec 2020 reached $1.3 million, up 104.86%, while the annual FY2020 figure was $1.3 million, 104.86% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2020 was $1.3 million at enVVeno Medical, down from $1.4 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $15.0 million in Q3 2019 and troughed at $630418.0 in Q4 2019.
  • A 4-year average of $6.7 million and a median of $6.1 million in 2017 define the central range for Shares Outstanding (Weighted Average).
  • On a YoY basis, Shares Outstanding (Weighted Average) climbed as much as 104.86% in 2020 and fell as far as 94.62% in 2020.
  • Year by year, Shares Outstanding (Weighted Average) stood at $6.1 million in 2017, then surged by 52.81% to $9.4 million in 2018, then plummeted by 93.27% to $630418.0 in 2019, then skyrocketed by 104.86% to $1.3 million in 2020.
  • Business Quant data shows Shares Outstanding (Weighted Average) for NVNO at $1.3 million in Q4 2020, $1.4 million in Q3 2020, and $797875.0 in Q2 2020.